The mechanism of interleukin (IL)-10-mediated inhibition of tumor necrosis factor (TNF)-α production was studied by lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. IL-10 inhibited TNF-α production transiently at an early stage after LPS stimulation. IL-10 inhibited the activation of nuclear factor (NF)-κB, p38 and stress-activated protein kinase (SAPK) in LPS-stimulated RAW 264.7 cells. Although the level of MyD88 protein increased in response to LPS, IL-10 prevented the LPS-induced MyD88 augmentation. There was no significant difference in the MyD88 mRNA expression between the cells pretreated with or without IL-10 in response to LPS. Therefore, IL-10 was suggested to inhibit LPS-induced TNF-α production via reduced MyD88 expression.
O'Neill LAHow Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol2006; 18: 3-9.
4.
Yamamoto M., Sato S.TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol2003; 4: 1144-1150.
5.
Kopp E., Medzhitov R.Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol2003; 15: 396-401.
6.
Wang P., Wu P., Siegel MI, Egan RW, Billah MMInterleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem1995; 270: 9558-9563.
7.
Schottelius AJ, Mayo MW, Sartor RB, Baldwin Jr ASInterleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor-kappaB DNA binding . J Biol Chem1999 ; 274: 31868-31874.
8.
Kontoyiannis D., Kotlyarov A., Carballo E. et al. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF-alpha mRNA translation and limit intestinal pathology . EMBO J2001; 20: 3760-3770.
9.
Qasimi P., Ming-Lum A., Ghanipour A. et al. Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor-alpha and nitric oxide production by macrophages . J Biol Chem2006; 281: 6316-6324.
10.
Wessells J., Baer M., Young HA et al. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem2004; 279: 49995-50003.
11.
Zou W., Amcheslavsky A., Takeshita S., Drissi H., Bar-Shavit Z.TNF-alpha expression is transcriptionally regulated by RANK ligand . J Cell Physiol2005; 202: 371-378.
Campbell J. , Ciesielski CJ, Hunt AE et al. Novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappaB with implications for therapy in rheumatoid arthritis. J Immunol2004; 173: 6928-6937.
14.
Yao J., Mackman N., Edgington TS, Fan STLipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem1997; 272: 17795-17801.
15.
Driessler F. , Venstrom K., Sabat R., Asadullah K., Schottelius AJMolecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol2004; 135: 64-73.
16.
Shames BD, Selzman CH, Meldrum DR et al. Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes . Shock1998; 10: 389-394.
17.
Clarke CJ, Hales A., Hunt A., Foxwell BMIL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF-kappaB activity. Eur J Immunol1998; 28: 1719-1726.
18.
Denys A., Udalova IA, Smith C. et al. Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappaB in primary human macrophages. J Immunol2002; 168: 4837-4845.
19.
Kuwata H., Watanabe Y., Miyoshi H. et al. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood2003; 102: 4123-4129.
20.
Williams L. , Bradley L., Smith A., Foxwell B.Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol2004; 172: 567-576.
21.
Berlato C., Cassatella MA, Kinjyo I. et al. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol2002; 168: 6404-6411.
22.
Baetz A., Frey M., Heeg K., Dalpke AHSuppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J Biol Chem2004; 279: 54708-54715.
23.
Weighardt H. , Kaiser-Moore S., Vabulas RM et al. Myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol2002; 169: 2823-2827.
24.
Kawai T., Adachi O., Ogawa T., Takeda K., Akira S.Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity1999; 11: 115-122.
25.
Naiki Y., Michelsen KS, Zhang W. et al. Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling . J Biol Chem2005; 280: 5491-5495.
26.
Lowe EL, Doherty TM, Karahashi H., Arditi M.Ubiquitination and de-ubiquitination: role in regulation of signaling by Toll-like receptors. J Endotoxin Res2006 ; 12: 337-345.
27.
Meylan E., Burns K., Hofmann K. et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappaB activation. Nat Immunol2004; 5: 503-507.
